Edwards Lifesciences Corp
EWHealth careStock · Data from SEC EDGAR 13F · Held by 12 of 87 tracked investors
Edwards Lifesciences Corp at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation19
- Growth77
- Profitability81
- Quality71
- Debt100
- Stability97
Earnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 23 Jul 2026 | 0.78 | 0.73 | +6.9% |
| Mar 2026 | 23 Apr 2026 | 0.78 | 0.75 | +4% |
| Dec 2025 | 10 Feb 2026 | 0.58 | 0.62 | -6.5% |
| Sep 2025 | 30 Oct 2025 | 0.67 | 0.59 | +13.6% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart EW
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
12DR David Rolfe Wedgewood Partners | 3.08% |
SC Steven Cohen Point72 Asset Management | 0.18% |
IE Israel Englander Millennium Management | 0.12% |
RD Ray Dalio Bridgewater Associates | 0.1% |
Ns Norský státní fond Norges Bank | 0.08% |
Šn Švýcarská národní banka Swiss National Bank | 0.08% |
Čn Česká národní banka Česká národní banka | 0.08% |
CA Cliff Asness AQR Capital Management | 0.05% |
KG Ken Griffin Citadel Advisors | 0.04% |
RB Ron Baron Baron Capital | 0.03% |
JG Joel Greenblatt Gotham Asset Management | 0.02% |
KF Ken Fisher Fisher Investments | 0% |
Frequently asked questions
How much is Edwards Lifesciences Corp (EW) stock?
Edwards Lifesciences Corp shares trade at $89.07, -1.13% over the last trading day. The price is delayed.
What is the market cap of Edwards Lifesciences Corp?
The market cap of Edwards Lifesciences Corp is about $51.3B and its price-to-earnings ratio (P/E) is 53.
How has Edwards Lifesciences Corp stock performed over the last year?
The Edwards Lifesciences Corp share price changed by +17.04% over 12 months and by -25.66% over 5 years.
Which big investors hold Edwards Lifesciences Corp?
According to the latest 13F filings, 12 of 87 tracked investors hold Edwards Lifesciences Corp, for example David Rolfe, Steven Cohen, Israel Englander.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.